Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction

International Journal of Cardiology

Volumn 191, Issue , 2015, Pages 314-319

  Kato, Shingo ^a   Saito, Naka ^a   Kirigaya, Hidekuni ^a   Gyotoku, Daiki ^a   Iinuma, Naoki ^a   Kusakawa, Yuka ^a   Iguchi, Kohei ^a   Nakachi, Tatsuya ^a   Fukui, Kazuki ^a   Futaki, Masaaki ^a   Iwasawa, Tae ^a   Taguri, Masataka ^b   Kimura, Kazuo ^c   Umemura, Satoshi ^d  

^a Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Heart failure; HFpEF; LGE MRI; Prognostic value

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; CARDIAC MUSCLE; CINE MAGNETIC RESONANCE IMAGING; FIBROSIS; HEART FAILURE; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; STROKE VOLUME;

EID: 84951826558     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.05.048     Document Type: Article

References (32)

1. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, A. Haouzi, Y. Gong, and P.P. Liu Outcome of heart failure with preserved ejection fraction in a population-based study N. Engl. J. Med. 355 2006 260 269
2. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr., D.W. Mahoney, K.R. Bailey, and R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
3. J.E. Udelson Heart failure with preserved ejection fraction Circulation 124 2011 e540 e543
4. M.R. Zile, W.H. Gaasch, I.S. Anand, M. Haass, W.C. Little, A.B. Miller, J. Lopez-Sendon, J.R. Teerlink, M. White, J.J. McMurray, M. Komajda, R. McKelvie, A. Ptaszynska, S.J. Hetzel, B.M. Massie, and P.E. Carson Mode of death in patients with heart failure and a preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction study (i-preserve) trial Circulation 121 2010 1393 1405
5. I. Paterson, and E.D. Michelakis The role of Doppler echocardiography in pulmonary artery hypertension: the importance of proving the obvious Chest 139 2011 973 975
6. E. Akiyama, S. Sugiyama, Y. Matsuzawa, M. Konishi, H. Suzuki, T. Nozaki, K. Ohba, J. Matsubara, H. Maeda, Y. Horibata, K. Sakamoto, K. Sugamura, M. Yamamuro, H. Sumida, K. Kaikita, S. Iwashita, K. Matsui, K. Kimura, S. Umemura, and H. Ogawa Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction J. Am. Coll. Cardiol. 60 2012 1778 1786
7. M. Ouzounian, D.S. Lee, and P.P. Liu Diastolic heart failure: mechanisms and controversies Nat. Clin. Pract. Cardiovasc. Med. 5 2008 375 386
8. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N. Engl. J. Med. 355 2006 251 259
9. R.J. Kim, D.S. Fieno, T.B. Parrish, K. Harris, E.L. Chen, O. Simonetti, J. Bundy, J.P. Finn, F.J. Klocke, and R.M. Judd Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
10. R.J. Kim, E. Wu, A. Rafael, E.L. Chen, M.A. Parker, O. Simonetti, F.J. Klocke, R.O. Bonow, and R.M. Judd The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N. Engl. J. Med. 343 2000 1445 1453
11. K.C. Wu, E.A. Zerhouni, R.M. Judd, C.H. Lugo-Olivieri, L.A. Barouch, S.P. Schulman, R.S. Blumenthal, and J.A. Lima Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
12. K.C. Wu, R.G. Weiss, D.R. Thiemann, K. Kitagawa, A. Schmidt, D. Dalal, S. Lai, D.A. Bluemke, G. Gerstenblith, E. Marban, G.F. Tomaselli, and J.A. Lima Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J. Am. Coll. Cardiol. 51 2008 2414 2421
13. R.G. Assomull, S.K. Prasad, J. Lyne, G. Smith, E.D. Burman, M. Khan, M.N. Sheppard, P.A. Poole-Wilson, and D.J. Pennell Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J. Am. Coll. Cardiol. 48 2006 1977 1985
14. O. Bruder, A. Wagner, C.J. Jensen, S. Schneider, P. Ong, E.M. Kispert, K. Nassenstein, T. Schlosser, G.V. Sabin, U. Sechtem, and H. Mahrholdt Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 56 2010 875 887
15. R. O'Hanlon, A. Grasso, M. Roughton, J.C. Moon, S. Clark, R. Wage, J. Webb, M. Kulkarni, D. Dawson, L. Sulaibeekh, B. Chandrasekaran, C. Bucciarelli-Ducci, F. Pasquale, M.R. Cowie, W.J. McKenna, M.N. Sheppard, P.M. Elliott, D.J. Pennell, and S.K. Prasad Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J. Am. Coll. Cardiol. 56 2010 867 874
16. R.Y. Kwong, A.K. Chan, K.A. Brown, C.W. Chan, H.G. Reynolds, S. Tsang, and R.B. Davis Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
17. A. Wagner, H. Mahrholdt, T.A. Holly, M.D. Elliott, M. Regenfus, M. Parker, F.J. Klocke, R.O. Bonow, R.J. Kim, and R.M. Judd Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 2003 374 379
18. W.J. Paulus, C. Tschope, J.E. Sanderson, C. Rusconi, F.A. Flachskampf, F.E. Rademakers, P. Marino, O.A. Smiseth, G. De Keulenaer, A.F. Leite-Moreira, A. Borbely, I. Edes, M.L. Handoko, S. Heymans, N. Pezzali, B. Pieske, K. Dickstein, A.G. Fraser, and D.L. Brutsaert How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur. Heart J. 28 2007 2539 2550
19. R.C. Semelka, E. Tomei, S. Wagner, J. Mayo, C. Kondo, J. Suzuki, G.R. Caputo, and C.B. Higgins Normal left ventricular dimensions and function: interstudy reproducibility of measurements with cine MR imaging Radiology 174 1990 763 768
20. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
21. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, M.R. Zile, S. Anderson, M. Donovan, E. Iverson, C. Staiger, and A. Ptaszynska Irbesartan in patients with heart failure and preserved ejection fraction N. Engl. J. Med. 359 2008 2456 2467
22. B.A. Borlaug, T.P. Olson, C.S. Lam, K.S. Flood, A. Lerman, B.D. Johnson, and M.M. Redfield Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction J. Am. Coll. Cardiol. 56 2010 845 854
23. A. Bouchard, C.B. Higgins, B.F. Byrd III, E.G. Amparo, L. Osaki, and R. Axelrod Magnetic resonance imaging in pulmonary arterial hypertension Am. J. Cardiol. 56 1985 938 942
24. B. Avitall, J. Bi, A. Mykytsey, and A. Chicos Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control Heart Rhythm. 5 2008 839 845
25. V.O. Puntmann, T. Voigt, Z. Chen, M. Mayr, R. Karim, K. Rhode, A. Pastor, G. Carr-White, R. Razavi, T. Schaeffter, and E. Nagel Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy J. Am. Coll. Cardiol. Img. 6 2013 475 484
26. E.S. Ford, W.H. Giles, and A.H. Mokdad The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III J. Am. Coll. Cardiol. 43 2004 1791 1796
27. D.M. Sado, S.K. White, S.K. Piechnik, S.M. Banypersad, T. Treibel, G. Captur, M. Fontana, V. Maestrini, A.S. Flett, M.D. Robson, R.H. Lachmann, E. Murphy, A. Mehta, D. Hughes, S. Neubauer, P.M. Elliott, and J.C. Moon Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping Circ. Cardiovasc. Imaging 6 2013 392 398
28. M. Fontana, S.M. Banypersad, T.A. Treibel, V. Maestrini, D.M. Sado, S.K. White, S. Pica, S. Castelletti, S.K. Piechnik, M.D. Robson, J.A. Gilbertson, D. Rowczenio, D.F. Hutt, H.J. Lachmann, A.D. Wechalekar, C.J. Whelan, J.D. Gillmore, P.N. Hawkins, and J.C. Moon Native T1 mapping in transthyretin amyloidosis J. Am. Coll. Cardiol. Img. 7 2014 157 165
29. J. Mascherbauer, B.A. Marzluf, C. Tufaro, S. Pfaffenberger, A. Graf, P. Wexberg, A. Panzenbock, J. Jakowitsch, C. Bangert, D. Laimer, C. Schreiber, G. Karakus, M. Hulsmann, R. Pacher, I.M. Lang, G. Maurer, and D. Bonderman Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction Circ. Cardiovasc. Imaging 6 2013 1056 1065
30. M.Y. Su, L.Y. Lin, Y.H. Tseng, C.C. Chang, C.K. Wu, J.L. Lin, and W.Y. Tseng Cmr-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF J. Am. Coll. Cardiol. Img. 7 2014 991 997
31. D. Bello, D.J. Shah, G.M. Farah, S. Di Luzio, M. Parker, M.R. Johnson, W.G. Cotts, F.J. Klocke, R.O. Bonow, R.M. Judd, M. Gheorghiade, and R.J. Kim Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy Circulation 108 2003 1945 1953
32. J. Matsubara, S. Sugiyama, T. Nozaki, K. Sugamura, M. Konishi, K. Ohba, Y. Matsuzawa, E. Akiyama, E. Yamamoto, K. Sakamoto, Y. Nagayoshi, K. Kaikita, H. Sumida, S. Kim-Mitsuyama, and H. Ogawa Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction J Am Coll Cardiol. 57 2011 861 869